Objectives: Pediatric obstructive sleep apnea (OSA) is a common disorder of childhood requiring many patients to undergo tonsillectomy and adenoidectomy. In patients with persistent OSA as determined by polysomnography, drug-induced sleep endoscopy (DISE) can determine the level of obstruction directly in patients with a severe Apnea-Hypopnea Index, and quite often, the adenoids are the biggest contributor to refractory disease. In pediatric patients (age 2-16 years) with persistent OSA (Apnea-Hypopnea Index 1.5-25.2) after primary tonsillectomy and adenoidectomy, our retrospective chart review set out to (1) describe the role of DISE for determining degree of adenoid regrowth following adenoidectomy and (2) recognize which subset of patients-developmental delays, allergic rhinitis, body mass index (BMI)-are susceptible to persistent adenoid hypertrophy despite previous adenoidectomy.
Methods: The information gathered for this study comes from clinical review of hospital records and documentation gathered from the West Virginia University Medicine system. Using a variety of images, video, and data from endoscopies of more than 128 patients from 2010 to 2015, 34 patients demonstrated persistent adenoid tissue.
Results: Of this group, 23 patients (67%) were described as having moderate-severe adenoid hypertrophy (>50% obstruction) despite their history of previous surgery. Developmental delay (approximately 25%), allergic rhinitis (20%), and BMI (56% with >95% BMI for age) were found to have very degrees of contribution to the level of adenoid regrowth. Our review confirms the role of DISE in describing the degree of adenoid regrowth in varying subsets of patients and which characteristics to be aware of when determining surgery for further treatment of OSA.
Awake Endoscopy versus Computed Tomography to Define lingual Tonsil Hypertrophy
Michael Friedman, MD (presenter); Jessica Tang, MD; Anna M. Salapatas, MS
Objectives:
The aims were to (1) analyze the correlation between endoscopic lingual tonsil grading versus computed tomography (CT) measurements of lingual tonsil thickness (LTT) and (2) identify the mean LTT based on CT for each lingual tonsil grade on awake endoscopy.
Methods: Patients who received both CT covering base of tongue and awake endoscopic grading of lingual tonsils between September and December 2016 were included. LTT was measured both axially and sagittally on CT. Each individual and mean LTT measurements were compared against endoscopic grading. One-way analysis of variance with Tukey's post hoc adjustment for multiple comparisons was performed.
Results: In total, there were 102 LTT measurements from 51 patients. For individual lingual tonsil measurements, LTH1 had a mean axial CT thickness of 6.06 ± 1.38 mm (n = 19), LTH2 6.58 ± 1.35mm (n = 69), and LTH3 8.44 ± 1.73 mm (n = 14) with significance among all groups (P < .0001). Statistical significance existed among all groups for both axial (P = .006) and sagittal (P = .040) CT measurements. Mean axial CT measurements were significantly different between LTH1 and LTH3 (P = .010) and between LTH2 and LTH3 (P = .009). Mean sagittal CT measurements were significantly different between LTH2 and LTH3 (P = .038).
Conclusions: Awake endoscopy grading of LTH is a subjective measurement that seems to correlate with objective CT measurements. LTT measurements of LTH1 and LTH2 on awake endoscopy differed significantly from LTH3.
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Objectives: Obstructive sleep apnea (OSA) is characterized by recurrent upper airway obstruction during sleep. OSA leads to high cardiovascular morbidity and mortality. The loss of motor input during sleep is associated with pharyngeal collapsibility and the development of OSA. Currently, there is no pharmacotherapy for sleep apnea. The objectives of this study were to determine (1) whether delivery of a specific excitatory gene to hypoglossal motoneurons improves upper airway patency and (2) whether delivery of a specific inhibitory gene to hypoglossal motoneurons induces OSA.
Methods: We used a chemogenetic approach. Excitatory and inhibitory designer receptors exclusively activated by designer drug, DREADDs (rAAV5-hSyn-hM3(Gq)-mCherry and rAAV5-hSyn-hM4(Gi)-mCherry), and control virus were stereotactically administered to the hypoglossal nucleus of C57BL/6J mice. In 6 to 8 weeks (expression period), genioglossus electromyography, dynamic magnetic resonance imaging of the upper airway, and sleep studies were performed before and after administration of the DREADD ligand clozapine-N-oxide (CNO) or vehicle (saline).
Results: In the excitatory DREADD experiments, CNO activated the genioglossus muscle (P > .001) and markedly dilated the pharynx, whereas saline had no effect. In the inhibitory DREADD experiments, CNO administration led to inspiratory flow limitation and obstructive hypopneas.
Conclusions: Our results demonstrate that chemogenetics can be used for studying upper airway neuromotor control and suggest that the transgenic approach may be effective in treating OSA as well as a wide range of disturbances in upper airway neural motor control that may affect swallowing, breathing, speech, and vocalization. Objectives: This study aims to evaluate the combination of genioglossus (GG) activity and anatomical characteristics in predicting outcomes of velopharyngeal surgery in patients with obstructive sleep apnea (OSA).
Combined Factors in Predicting the
Methods: Forty patients with OSA underwent overnight polysomnography with synchronous GG electromyography (EMG) using intraoral electrodes. The upper airway anatomy was evaluated by 3-dimensional computed tomography in patients with OSA. All patients received the same type of velopharyngeal surgery, consisting of revised uvulopalatopharyngoplasty with uvula preservation and concurrent transpalatal advancement pharyngoplasty. We followed up all patients using polysomnography for at least 3 months postoperatively.
Results: Twenty-five patients (62.50%) were responders, and 15 patients (37.50%) were nonresponders. The decreased Apnea-Hypopnea Index was significantly positively correlated with the sleep onset GG EMG (P = .006) but was negatively correlated with the change in GG EMG (P = .013) and tonic GG EMG (P = .018). Multiple regression analysis revealed that the minimal cross-sectional airway area at the velopharynx (odds ratio [OR], 1.760; P = .019) and the sleep onset GGEMG (OR, 0.322; P = .043) were significant predictors for surgical outcomes. When the 2 predictors were combined, the area under the receiver-operating characteristic curve was 0.901 (OR, 0.789; P = .001) for surgical success, and this was more valuable than any one predictor.
Conclusions: The combination of sleep-onset GG EMG and cross-sectional airway area at the velopharynx can predict the outcome of velopharyngeal surgery in patients with OSA. Methods: This was a case series. Patients who underwent HNS implantation (n = 20), all with moderate to severe OSA, inability to adhere to positive pressure therapy, and compliant with previously published inclusion criteria, were compared to a historical cohort that were intolerant of CPAP with similar inclusion criteria who all underwent UPPP (n = 20) with some also undergoing additional procedures such as septoplasty/turbinate reduction. Data, including body mass index (BMI) and pre-and postimplant apnea-hypopnea index (AHI), were assessed.
Conventional
Results: For patients who underwent HNS, median preoperative BMI was 27.9. Mean AHI decreased significantly from 40.8 ± 12.5 to 4.6 ± 3.6. All patients achieved an AHI < 11 post-implant, with 75% (15/20) with an AHI ≤ 5. For patients who underwent traditional airway surgery, median preoperative BMI was 27.5; mean AHI decreased from 40.3 ± 12.4 to 28.8 ± 25.4.
Conclusions: While both traditional surgery and HNS are effective treatments for patients with moderate to severe OSA with CPAP intolerance, our study demonstrates that HNS is "curative" in normalizing the AHI to less than 5 in the majority of patients. For select patients, upper airway stimulation therapy provides excellent objective improvement in outcome measures.
P168

Otolaryngology-Head and Neck Surgery 157(1S)
Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 17, 2017. Objectives: To examine drug-induced sleep endoscopy (DISE) findings in the supine versus lateral body positions in positional and nonpositional obstructive sleep apnea (OSA).
Methods: Cross-sectional study evaluating individuals with obstructive sleep apnea undergoing DISE in both the supine and lateral body positions. DISE findings were scored using the VOTE (velum, oropharynx, tongue base, epiglottis) classification, separately for the supine and lateral body positions. Differences in DISE findings for the supine versus lateral body positions were examined for 150 (75 positional and 75 nonpositional) individuals with OSA, from 2014 to 2017. Chisquared and McNemar's tests were used to evaluate DISE findings in the supine versus lateral body positions in the positional and nonpositional groups and then for the positional versus nonpositional OSA groups.
Results: Velum-and tongue-related obstruction was more common and more pronounced in the supine position as compared with the lateral body position (P < .05). Oropharyngeal lateral wall-related obstruction was more pronounced in the lateral body position (P < .05). There was no association between body position and epiglottis-related obstruction. These findings were seen in both the positional and nonpositional OSA groups. In the positional OSA group, changes in body position were associated with notable improvement in airway obstruction. In most (53%) individuals in the nonpositional OSA group, decreases in airway obstruction related to specific structures were offset by increases in airway obstruction related to other structures.
Conclusions: DISE findings differ in many patients in the supine versus lateral body positions, both in positional and nonpositional OSA. Objectives: Successful surgical management of obstructive sleep apnea (OSA) is based on determining the pattern of upper airway obstruction and design of a tailored treatment. Drug-induced sleep endoscopy (DISE) is an evaluation using pharmacologic sedation designed to simulate natural sleep. DISE has shown promise in studies at single institutions or single interventions. The objective of this study was to examine the association between DISE findings and surgical outcomes across multiple institutions and surgical procedures.
Drug-induced Sleep Endoscopy and Surgical
Methods: This was a retrospective cohort study of adults who underwent surgery for obstructive sleep apnea, with preoperative recorded DISE video and both preoperative and postoperative sleep studies. The preoperative recorded DISE videos were reviewed by 4 reviewers in a blinded fashion using the VOTE (velum, oropharynx, tongue base, epiglottis) classification. Surgical outcomes were defined by change in the Apnea-Hypopnea Index and the commonly-used definition of surgical response. Multiple linear and logistic regression evaluated potential associations between preoperative DISE findings and surgical outcomes. These analyses were performed for the entire cohort and for subgroups defined by specific DISE findings and surgical interventions. Statistical adjustment was performed for demographic and specific physical examination findings.
Results: Fourteen institutions contributed a total of 628 study participants. Two DISE findings were broadly associated with poorer outcomes: complete concentric collapse related to the velum/palate and complete oropharyngeal lateral wall collapse. Soft palate surgery outcomes were better in cases with isolated soft palate obstruction. Multilevel surgery that matched multilevel obstruction on DISE improved outcomes in selected instances.
Conclusions: DISE may characterize specific patient subgroups that may not respond well to surgery. DISE may also improve the design of effective surgical treatment plans.
Five-Grade Vocal Cord Grading System for the Hypopharynx
Carlos A. Torre, MD (presenter); Soroush Zaghi, MD; Macario Camacho, MD; Robson Capasso, MD; Stanley Yung-Chuan Liu, MD Objectives: Our goal was to assess the feasibility of adopting existing grading systems for hypopharyngeal examination during direct laryngoscopy (Cormack-Lehane and Modified Cormack-Lehane scales) for use in awake fiber-optic laryngoscopy examination of the hypopharynx in patients with obstructive sleep apnea (OSA). We also aimed to propose and validate a grading system specific to awake fiber-optic laryngoscopy for hypopharyngeal examination in patients with OSA
Methods: This was a retrospective case series conducted at the Stanford Sleep Surgery Clinic on 274 consecutive OSA patients. Single still images from awake fiber-optic laryngoscopy examinations of the vocal cords from 90 different patients were presented to 8 attending physician raters. Raters used 4 grading systems (Cormack-Lehane scale, modified Cormack-Lehane scale, 4-grade vocal cord grading system, and 5-grade vocal cord grading system) to rate vocal cord visualization. Percentage agreement and Cohen κ statistical analysis was used to evaluate interrater reliability and intrarater reliability for each grading system.
Results: The modified Cormack-Lehane scale communicates unobstructed and restricted views of the vocal cords reliably. Compared with the 4-grade scale, a modified 5-grade vocal cord grading system allows for better objective discrimination of common variations in hypopharyngeal airway visualization. When all the scales were compared, the 5-grade vocal cord grading system had the highest interrater and intrarater reliability across categories.
Conclusions: We propose a 5-grade vocal cord grading system that provides reliable and reproducible hypopharyngeal airway examination during awake fiber-optic laryngoscopy. Results: Baseline and 1-year to 5-year Apnea-Hypopnea Index (events/h) decreased (n = 37), median (29 to 9.4 to 7.0), mean (SD) of 31.3 (9.4), to 17.1 (17), to 14 (18; P = .001), oxygen saturation (SAO 2 ) improved by <90% (4.72%, 0.43%, to 1.36%), sleepiness and quality of life normalized (Epworth Sleepiness Scale = 11.4 [5.5], 6.9 [4.6], to 6.8 [4.6], P = .0001; and Functional Outcome of Sleep questionnaire = 14.8 [2.6], 17.5 [2.6], to 18.0 [2.4], P = .0001). Twelve-month responder percentage improved from 65% to 71%, with 7 of 11 nonresponders converting to responders while 5 of 26 responders converted to nonresponders. BMI did not change responders' Apnea-Hypopnea Index. Soft or no snoring at baseline (42%) improved to 85% and 89% at 1 and 5 years. Baseline, 12-month, and 60-month sensory (1.0, 1.0, to 0.7 V), functional (1.7, 1.7, to 0.7 V), and subdiscomfort (2.4, 2.5, to 2.0 V) stimulation thresholds decreased over time.
Conclusions: Cranial nerve stimulation demonstrates significant clinical improvements at 1 year that are maintained at 5 years. Adverse effects of BMI changes or stimulation thresholds were not observed. Objectives: Obstructive sleep apnea reduces sexual quality of life (QOL) through reduced libido, reduced intimacy, erectile dysfunction, and other mechanisms. We tested the impact of long-term continuous positive airway pressure (CPAP) on sexual QOL.
Methods: This prospective cohort study included patients with newly diagnosed sleep apnea who were prescribed CPAP and stratified into users (>4 h/night) or nonusers (<0.5 h/ night). Data were collected before CPAP and 12 months later, including the validated symptoms of nocturnal obstruction and related events QOL instrument. We created a sexual QOL domain from the 2 sex-specific items, scored 0 to 5 (higher is worse). We tested the difference in sexual QOL between CPAP users and nonusers with the t test and multivariate linear regression, adjusting for potential confounders.
Results: On average, the cohort (n = 182) was middle-aged (47 ± 12 years), included both sexes (63% men), and had severe sleep apnea (Apnea-Hypopnea Index 33 ± 24 events/h). At 12 months, CPAP users (mean use 6.4 ± 1.2 h/night, n = 72) had greater improvement than nonusers (mean use 0.0 ± 0.0 h/night, n = 110) on sexual QOL (0.68 ± 0.14 vs 0.14 ± 0.11, difference 0.54, 95% confidence interval [CI] 0.18-0.90, P = .004). The effect persisted after adjusting for age, sex, race, body mass index, Apnea-Hypopnea Index, and the Functional Comorbidity Index (difference 0.33, 95% CI -0.06 to 0.71, P = .09). Subgroup analysis revealed a treatment effect in women (adjusted difference 0.88, 95% CI 0.08-1.69, P = .03) but not men (adjusted difference 0.03, 95% CI -0.38 to 043, P = .90).
Conclusions: Successful CPAP use appears to improve sexual QOL in women but not men. Further study is warranted to test other measures of sexual QOL and other treatments. Results: We assessed 68 families. Patients had a mean age of 12.5 ± 2.9 years (range 6.7-23.6), and 28% were female. The mean Apnea-Hypopnea Index (AHI) was 10.43 ± 10.51 (range 0.1-39.8) and mean obstructive AHI was 9.70 ± 10.20 (range 0-39.8). The mean FIS score was 42.89 ± 14.67 (range 7-87). The negative impact subscale score was 22.96 ± 2.25 (range 0-31), which is similar to those for children living with developmental disabilities (19.63-28.23, SD 5.07-13.07). Negative impact areas included feelings about parenting and impact on social relationships. There was a weak correlation between obstructive AHI and FIS (r = .18) and no difference by OSA severity (with P = .39) Higher FIS scores had a moderate correlation with PedsQL scores (r = .41). Higher OSA severity (moderate and severe) was associated with a higher symptom scores (pediatric sleep questionnaire) when answered by patients (29.63 ± 17.47, range 0-74, P = .036) but not when answered by parents (29.24 ± 13.57, range 3-66, P = .338)
Conclusions: The impact of pediatric OSA on family functioning is significant and similar to children with developmental delay. Higher FIS scores had a moderate correlation with PedsQL scores. Objectives: To provide new insights into therapeutic approaches aiming to resolve frequent pediatric obstructive sleep apnea with tonsillar hypertrophy without surgical removal, we have reported the significant size reduction of palatine tonsils after repeated topical corticosteroids injections in a rabbit model. The purpose of this study is to determine if single intratonsillar injection of steroid (mometasone) nanoparticles can reduce the size of palatine tonsils in a rabbit model via sustained release.
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Methods: Poly(lactic-co-glycolic acid) (PLGA) nanoparticles of mometasone were prepared and characterized for the intratonsillar injection. The tonsils of rabbits were injected either with mometasone nanoparticles (n = 4, 1 mg/0.1 mL) or nanoparticles alone (n = 4, 0.1 mL). Rabbits were then followed for 8 weeks after single injection and harvested for histologic analysis.
Results: Sustained release of mometasone was obtained from the nanoparticles. A total of 16 tonsils (mometasone nanoparticle:nanoparticle alone = 8:8) were analyzed. The tonsils that received the mometasone nanoparticles were significantly smaller than the nanoparticle alone-injected tonsils at week 3 and week 8 (P < .05). In histologic analysis, the tonsils that received the fluticasone nanoparticle injections were significantly smaller than the tonsils injected with nanoparticle alone (P < .05). Lymphoid follicles were not well visualized in tonsils injected with mometasone nanoparticles.
Conclusions: We investigated the size of palatine tonsils of rabbit after single intratonsillar injection of mometasone nanoparticles whether single PLGA nanoparticles based mometasone can replace multiple steroid injections. Single intratonsillar injection of mometasone nanoparticles reduces the size of tonsils without regrowth for 8 weeks. Methods: The adherence and outcome of UAS for OSA (ADHERE Registry) is a registry of patients implanted with an UAS system. It collects patient outcome measures and therapy adherence from the therapy titration visit and at a 12-month visit postimplant. Outcome measures include the pre-and postimplant Apnea-Hypopnea Index (AHI) and the Epworth Sleepiness Scale. The postimplant AHI is measured during the in-laboratory polysomnographic titration study and at 12 months with polysomnograph or home sleep testing.
Outcomes of upper Airway Stimulation: results from a Multicenter registry
Results: As of January 24, 2017, a total of 100 participants enrolled in the registry. The mean age was 61.1 ± 11.3 years (85% male) and body mass index of 29.4 ± 3.6 kg/m 2 . The AHI was reduced from a baseline of 38.9 ± 16.2 to 5.9 ± 10.2 and 7.6 ± 8.3 events/h at the titration and 12-month visits. The Epworth Sleepiness Scale changed from 11.6 ± 6.2 to 6.7 ± 4.6 and 6.2 ± 4.1 at the titration and final visit. Therapy adherence was 6.5 ± 1.9 and 5.9 ± 2.3 h/night at the titration and the 12-month visit.
Conclusions: UAS reduced OSA severity and improved measures of daytime sleepiness. The adherence remained high after 12 months among participants. Methods: In this ongoing prospective study beginning July 2016, consecutive patients presenting for evaluation of obstructive sleep apnea (OSA) or chronic rhinosinusitis (CRS) were given patient global impression questionnaires consisting of 3 stages in which patients identify the most important areas of their lives affected by OSA, score the degree to which each area is affected, and allocate points to represent the amount in which they would like each area improved. Each area designated by the patient was subsequently categorized into areas of QOL concerns. Follow-up responses were compared after treatment intervention, and patients were given the opportunity to add new responses.
Results: In total, 106 OSA patients and 119 CRS patients were enrolled in the study. Areas of concerns voiced by OSA patients that are not addressed in other OSA questionnaires, such as Sleep Apnea Quality of Life Index, Functional Outcomes of Sleep Questionnaire, and Epworth Sleepiness Scale, were sex (20.8%), hobbies/being creative (18.9%), money/security (9.4%), personal (7.5%), and spiritual (5.7%). Similarly, areas of concerns voiced by CRS patients not addressed in the 22-item Sinonasal Outcome Test were sex (14.3%), hobbies/being creative (21.0%), money/security (10.9%), personal (4.2%), and spiritual (3.4%). Other areas mentioned by both groups included relationships with partners/family, work/productivity, fitness, concern for health, socializing, energy, sex, and mental health/mood.
Conclusions: Issues that both OSA and CRS patients identified in significant percentages include sex, creativity, money/ security, spirituality, and personal aspects such as making a difference. Patient global impression can be a unique tool to
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Oral Presentations P171 evaluate QOL described in the patient's own terms, and questionnaires should aim to address these concerns. Methods: Prospective case series for children and infants with persistent OSA referred to a multidisciplinary upper airway clinic from 2014 to 2016 at a tertiary pediatric center. Patients and their families completed polysomnography and validated questionnaires for QOL, including the Family Impact Survey (FIS) and the Pediatric Quality of Life (PedsQL) Inventory. They completed these same surveys at clinic followup. We then evaluated their results with the OSA severity. Pearson correlation and t-tests were used for analysis.
Patients PedsQl Scores
Results: Twenty-three patients and families were included. Patients had a mean age of 13.22±1.08 years, and 30.4% were female. Pretreatment, the mean apnea-hypopnea index (AHI) was 15.01±6.88 events/hour and mean obstructive AHI (oAHI) was 15.38±6.89 events/hour. After treatment, the mean AHI was significantly lower at 4.16±2.42 events/hour (P = .004) and mean oAHI was 3.93±2.35 events/hour (P = .003). The PedsQL completed by affected children improved from 44.13±13.78 to 24.2±9.13 events/hour (P = .011); the correlation with OSA severity was weak (r = 0.35). However, the PedsQL completed by parents did not significantly change with treatment (34.55 before vs 34.91 after, P = .945) and there was no significant correlation (r = .12).
Conclusions: For children treated for persistent pediatric OSA, PedsQL scores significantly improved with treatment and correlated with oAHI improvement. However, the PedsQL scores completed by parents did not improve with treatment and did not correlate with improvement in oAHI.
Surgical Anatomy of the Distal Hypoglossal Nerve
Zachary N. Robinett, MD (presenter); Douglas J. Van Daele, MD; Andrew Goates Objectives: To establish anatomic landmarks that are surgically relevant to the submandibular approach used in selective hypoglossal nerve (HGN) stimulation surgery.
Methods: On 26 embalmed cadavers, all branches of the distal HGN were skeletonized including lateral HGN, medial HGN, geniohyoid, and genioglossus horizontal (GGh). Several anatomic relationships were hypothesized and evaluated by measuring distances between nerve branches along the length of the HGN and by measuring distances between nerve branches and structures within the typical surgical field. Distances were expressed as mean ± SD. One-proportion confidence intervals were calculated (95% confidence level) for each hypothetic relationship.
Results: Mean ± SD distances from the posterior edge of mylohyoid (PMH) were 1.1 ± 1.9, 0.7 ± 2.5, and 7.4 ± 2.4 mm to the lateral-HGN, GH, and GGh branches, respectively. Mean distance between the most distal GGh branch and the anterior edge of hyoglossus (AHG) was 2.0 ± 1.7 mm. The HGN was identified ≤10 mm superior to the tip of the greater cornu of the hyoid in 91% ± 9% specimens. All GGh branch points occurred ≤4 mm (proximal or distal) from the AHG in 88% ± 10% of specimens. A 10-× 20-mm box centered and based on the point of PMH and hyoid bone intersection outlined a site of likely successful selective electrode placement in 79% ± 11% of specimens.
Conclusions: In the submandibular surgical field, the PMH, AHG, the hyoid bone appear to be consistently useful landmarks for identifying the HGN and its branches and may aid in successfully placing selective HGN stimulating electrodes. Objectives: The aims of this study were to (1) assess the rate of postoperative dysphagia after upper airway stimulation (UAS) using the Eating Assessment Tool (EAT-10) swallowing questionnaire and (2) compare pre-and postoperative swallowing assessments to assess for dysphagia.
Methods: We conducted a prospective swallowing assessment, using the EAT-10 dysphagia questionnaire, of all patients at our institution undergoing UAS from April to December 2016. We collected demographic data including age, sex, body mass index (BMI), and pre-and postoperative polysomnography results. Patients were asked to complete the EAT-10 questionnaire prior to surgery and again at their 6-month follow-up visit.
Results: Nineteen patients met the inclusion criteria: 12 men and 7 women, with a mean ± SD age of 61.11 ± 9.39 years and BMI of 35.53 ± 15.29 kg/m 2 . The mean ± SD preoperative Apnea-Hypopnea Index and O 2 nadir were 41.99 ± 26.59 and 76.94 ± 14.89, respectively. The mean ± SD postoperative Apnea-Hypopnea Index and O 2 nadir were 4.78 ± 4.20 and 89.27 ± 2.09, respectively. The mean ± SD preoperative EAT-10 score was 1.67 ± 2.36. The mean ± SD postoperative EAT-10 score was 2.65 ± 7.41, which was not significantly higher than the preoperative value (P = .455). The postoperative score was obtained at an average of 186.76 ± 58.78 days postoperatively.
Conclusions: UAS therapy for treatment of obstructive sleep apnea does not result in postoperative dysphagia. 
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Objectives: The aims were to (1) analyze the effect of hypoglossal nerve stimulation (HNS) on somnography outcomes, quality-of-life, and cardiopulmonary comorbidities in patients with obstructive sleep apnea (OSA) and (2) describe how preand postoperative factors influence device efficacy.
Methods: Patients with moderate to severe OSA who exhibit anterior-posterior velopharyngeal collapse on sleep endoscopy underwent HNS implantation. Demographics, cardiopulmonary comorbidities, Epworth sleepiness scores, and polysomnography measures were collected preoperatively. Postoperatively, device titration parameters, compliance, repeat polysomnography, tongue protrusion patterns, Epworth sleepiness scores, cardiopulmonary conditions, and complications were assessed. A nonparametric Wilcoxon signed-rank test was used to compare pre-and postoperative ApneaHypopnea Index (AHI).
Results: Twenty-nine patients from Middlesex Hospital and New York Presbyterian underwent HNS implantation between December 2014 and October 2016. Mean age was 52.9 ± 8.2 years, and 6 individuals (20.6%) were women. Mean preoperative body mass index was 28.6 ± 3.6 kg/m 2 . Postoperative AHI was significantly reduced (45.4 ± 16.9 to 8.7 ± 16.1, P < .001). Fifteen patients (51.7%) achieved a treatment AHI <5. Twenty-four (82.8%) patients achieved a treatment AHI <15. Mean compliance was 50.3 ± 9.2 h/wk. Complications were rare: 2 patients reported persistent pain, 1 developed a hypertrophic scar, and there was 1 case of mild tongue paresis, which resolved spontaneously.
Conclusions: Preliminary data show that HNS is a safe procedure associated with improved OSA outcomes. Efforts are ongoing to examine the influence of airway collapse, device titration, and tongue protrusion on device efficacy. As patients are followed for multiple years, the effect of HNS on cardiopulmonary comorbidities will be further assessed. Methods: This prospective study in 3 German centers enrolled consecutive patients with Apnea-Hypopnea Index of 15/h to 65/h, aged between 15 and 65 years, and with body mass index (BMI) <35 kg/m², who received a UAS implant (Inspire Medical Systems). Data collection included baseline characteristics and postoperative home sleep apnea test and patientreported outcome of Epworth Sleepiness Scale and Functional Outcome of Sleep Questionnaire at 6 and 12 months.
Results: The study enrolled 60 patients aged 56.8 ± 9.1 years (58 men, 2 women) and BMI 28.8 ± 3.6 kg/m 2 . Among them, the Apnea-Hypopnea Index changed from 28.6 ± 13.2 to 9.5 ± 14.8 (P < .05), Epworth Sleepiness Scale from 13.0 ± 5.3 to 6.5 ± 4.5 (P < .05), and Functional Outcome of Sleep Questionnaire from 13.7 ± 3.6 to 17.5 ± 3.0 (P < .05) from baseline to 6 months. Methods: We reviewed our series of patients undergoing UAS and identified those having undergone prior sleep surgery. We defined prior sleep surgery as unsuccessful if there was a residual Apnea-Hypopnea Index (AHI) >20. We collected demographic data, Epworth Sleepiness Scale (ESS) score results, and polysomnographic data. Surgical success was defined as a decline in postoperative Apnea-Hypopnea Index by 50% and to a value <20. We then compared these patients to a cohort who had not undergone prior sleep surgery.
Results: To date, we have performed 78 UAS implantations at our institution. Of these patients, 13 have undergone prior surgery for obstructive sleep apnea (OSA). This included 9 uvulopalatopharyngoplasties, 3 maxillomandibular advancements, and 1 tongue base resection. The patients undergoing prior sleep surgery were 7 men and 6 women. The mean preoperative ESS, AHI, and O 2 nadir values were 9.78, 34.75, and 81, respectively. The mean postoperative ESS, AHI, and O 2 nadir values were 6.7, 7.8, and 87.8, respectively. Postoperative AHI was significantly improved from preoperative (P < .0001). The surgical success rate was 90.91%. Compared with outcome measures of a cohort of patients who received UAS implantation, but not other types of sleep surgery, there was no significant difference in postoperative AHI, O 2 nadir, ESS, or success rate. Conclusions: UAS is a successful method of treating OSA and can be used to treat patients who have failed other types of sleep surgery. 
What Determines Good Maxillomandibular
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higher demand for favorable fracture and fixation of the mandible due to large advancement. We identify surgeon and patient factors that influence favorable mandibular fracture and fixation pattern in MMA.
Methods: This was a retrospective cohort study of 46 patients (43 men) with mean age of 40.1 ± 11.5 years who underwent MMA at Stanford (S.Y.-C.L., R.W.R.) from 2014 to 2016 with postoperative computed tomography facial bone reconstruction. Surgical parameters assessed included (1) ramus osteotomy past the mandibular foramen and (2) anterior body osteotomy related to the midline inferior border. Patient factors included age, body mass index, ApneaHypopnea Index, and lowest oxygen saturation. Outcome parameters were adequate area of passive bony contact and quality of rigid fixation determined by buccal and lingual plate width. Univariate and multivariate logistic regression analyses were performed with significance set at P < .05.
Results: Osteotomy past the mandibular foramen and anterior body osteotomy just to the midline of the inferior border are significantly associated with favorable fracture and fixation pattern (odds ratio [OR] = 15.9, P = .015 and OR = 9.7, P = .036, respectively). With multivariate analysis including patient parameters, ramus osteotomy past mandibular foramen, anterior osteotomy short of inferior midline, and lowest oxygen saturation were significantly associated with favorable fracture and fixation pattern (OR = 6.6, P = .04).
Conclusions: Surgeon factors of osteotomy to the mandibular foramen and extent of inferior border osteotomy, along with OSA patient factor of lowest oxygen saturation, are predictive of favorable fracture and fixation pattern in MMA.
